Product Information
SULFACETAMIDE-SULFUR 8-4% SUSP is a generic product labeled by Acella Pharmaceuticals, LLC, priced at $0.0710 per ML under NDC 42192013316. Its NADAC has been published 448 times since Oct 18, 2017.
Strength
80; 40 mg/mL; mg/mL
Manufacturer
Acella Pharmaceuticals, LLCNDC
42192013316
Classification
Generic
Dosage Form
SOLUTION
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
SULFACETAMIDE SODIUM; SULFURApproval Type
Unapproved
On Market Since
5/13/2011
Pharmacological Classes
Price Statistics
The NADAC for SULFACETAMIDE-SULFUR 8-4% SUSP has been published 448 times since Oct 18, 2017, and over the history we have for it it has declined 54.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0710 per ML |
|---|---|
| All-time high | $0.1731 (Sep 11, 2019) |
| All-time low | $0.0612 (Apr 22, 2026) |
| 52-week high | $0.0814 |
| 52-week low | $0.0612 |
| Median price | $0.1213 |
| Average price | $0.1178 |
| Largest weekly change | +55.8% (Jan 19, 2022) |
| Weeks tracked | 448 |
| Tracking since | Oct 18, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Sodium Sulfacetamide and Sulfur market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Acella Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sodium Sulfacetamide and Sulfur market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sulfonamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SULFACETAMIDE-SULFUR 8-4% SUSP?
The current National Average Drug Acquisition Cost (NADAC) for SULFACETAMIDE-SULFUR 8-4% SUSP, manufactured by Acella Pharmaceuticals, LLC, is $0.0710 per ML (NDC 42192013316), effective Sep 30, 2026.
How has the price of SULFACETAMIDE-SULFUR 8-4% SUSP changed over time?
Over the history we have for it, the NADAC for SULFACETAMIDE-SULFUR 8-4% SUSP has declined 54.8%. It has been tracked across 448 weekly CMS publications since Oct 18, 2017.
What are the highest and lowest recorded NADAC prices for SULFACETAMIDE-SULFUR 8-4% SUSP?
Since Oct 18, 2017, the NADAC for SULFACETAMIDE-SULFUR 8-4% SUSP has ranged from a low of $0.0612 (Apr 22, 2026) to a high of $0.1731 (Sep 11, 2019), with a median of $0.1213 per ML.
Are there cheaper alternatives to SULFACETAMIDE-SULFUR 8-4% SUSP?
No other NADAC-published product currently shares the active ingredient and strength of SULFACETAMIDE-SULFUR 8-4% SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SULFACETAMIDE-SULFUR 8-4% SUSP?
SULFACETAMIDE-SULFUR 8-4% SUSP (NDC 42192013316) is labeled by Acella Pharmaceuticals, LLC, and CMS classifies it as a generic product.